Early Results Of a Phase II Study Of Lenalidomide and Rituximab As Frontline Treatment Of Patients With Chronic Lymphocytic Leukemia »
04/08/14

Hypogammaglobulinemia In Patients With Previously Untreated Chronic Lymphocytic Leukemia: Clinical Correlates and Outcomes »
04/08/14

Profiles Of De Novo CD25-Positive Mature B-Cell Lymphomas »
04/08/14

High Dose Cyclophosphamide (HDCy) Post Stem Cell Transplant (SCT) Following High Dose Melphalan (HDMel) Based Conditioning As a Dual Strategy For Chemotherapy Dose Intensity and Graft Versus Host Disease (GvHD) Prophylaxis In Matched and Mismatched allo-SCT »
04/08/14

Preclinical Development Of ROR1 Peptide Based Vaccine With Activity Against Chronic Lymphocytic Leukemia In ROR1 Transgenic Mice »
04/08/14

Single Agent Ibrutinib (PCI-32765) »
04/08/14

Regulation Of CLL Growth and Trafficking »
04/08/14

Daratumumab, a Novel Human Anti-CD38 Monoclonal antibody »
04/08/14

TP53 Disruption and Telomere Instability In Chronic Lymphocytic Leukemia »
04/08/14

Ibrutinib In Combination With Rituximab »
04/08/14